Popular Articles

FDA Approves VYVANSE CII Label Change To Include Supplementary Clinical Data Supporting Efficacy At 13 Hours Postdose In Children Age 6-12 With ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment VYVANSE® (lisdexamfetamine dimesylate) CII, to include supplemental data that demonstrated significant ADHD symptom control in children aged 6 to 12 from the first time point measured (1.5 hours) through 13 hours postdose. VYVANSE is now the first and only oral ADHD stimulant treatment to have 13-hour postdose efficacy data for pediatric patients included in its product labeling.
generic viagra online
Also In Global Health News: Fortified-Rice; Fake Malaria Drugs; HIV In Philippines; Male Circumcision; Uganda DDT Spraying
Indian
News of the day
Statement From American Association Of Kidney Patients Kidney Failure Is No Laughing Matter
The American Association of Kidney Patients (AAKP) is very disappointed with Wanda Sykes" comedic comments regarding kidney failure and Rush Limbaugh at the White House Correspondent Dinner over the weekend. While Ms. Sykes" comments were most likely made in a light-hearted manner, hundreds of thousands of kidney disease patients and their loved ones do not see kidney failure as a laughing matter. Nearly 400,000 Americans are receiving dialysis as a life saving treatment for kidney failure and 26 million Americans have been diagnosed with chronic kidney disease (CKD), which means they are at risk for losing their kidney function. In addition, 20 million Americans are at risk for CKD and do not even know it.
Nutrition

The Sweet Taste Of Uncertainty: Winners Enjoy Waiting To Discover What They've Won

You"ve just won a prize. Would you like to find out what it is right away, or wait until later? A new study in the Journal of Consumer Research says most people are happier waiting. People who know they"ve won a prize enjoy the anticipation of wondering what they will win, especially if they have clues about what it might be, explain authors Yih Hwai Lee (National University of Singapore) and Cheng Qiu (University of Hong Kong). Prize winners spend time imagining using the potential prizes, and such "virtual consumption" prolongs positive feelings, making them receptive to marketing messages. The authors conducted two studies where participants played and won simulated lucky-draw games. Some learned what their prizes were immediately; others were told they had won something from a pool of prizes. "We find that consumers will be more delighted after winning a lucky draw when they do not know immediately the exact prize they will receive than when they do," the authors write. Participants who got clues about the nature of the possible prizes (such as knowing it was an electronic product) responded even more favorably. They also favored prizes that were capable of eliciting mental imagery, like sensory-stimulating products such as chocolates or aromatherapy candles. (Apparently, functional items like cutlery and digital clocks failed to stimulate.) "Consumers in happier moods have been found to react more favorably to marketing information and activities," write the authors. "Our research suggests that by incorporating positive uncertainty into the design of marketing activities (for example, in promotional events), marketers may not only make consumers happier, but also make them potentially more receptive toward subsequent marketing efforts." Yih Hwai Lee and Cheng Qiu. "When Uncertainty Brings Pleasure: The Role of Prospect Imageability and Mental Imagery." Journal of Consumer Research: December 2009 (published online April 22, 2009). Mary-Ann Twist University of Chicago Press Journals


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):